Sponsored by:
Facebook (FB)
JP Morgan (JPM)
AutoZone (AZO)
Yahoo (YHOO)
Focus Stocks
Featured Stories
Medtronic Reports Fourth Quarter Earnings
Cracker Barrel Reports Earnings, Increases Guidance
Best ETFs For Facebook Exposure
Is Yum! Brands Closing in to Support?
Intuitive Surgical Bullish Signs
Eli Lilly Lower With High Volume
Published on Thursday, 05 January 2012 11:38 Written by TradersHuddle Staff
New York, January 5th (TradersHuddle.com) - Unusual high volume detected on shares of Eli Lilly & Co. (NYSE:LLY), early in the trading session. Eli Lilly is currently trading lower by 2.16%, so definitely the sellers in control, as the stock's volume is on pace to break its average.
Eli Lilly (NYSE:LLY) principal activities are to develop, manufacture and market pharmaceutical-based health care solutions. The company specializes in research and development, production and marketing of products for the treatment of diabetes worldwide, such as insulin and insulin delivery devices.. Some of the company's patents include Zyprexa, Prozac, Permax, Humulin, Evista, Humalog, Humatrope, Vancocin, Keflex, Nebcin , Lorabid, Gemzar, Tylan, and Rumensin.
Eli Lilly has already traded 0.826 times its 3-month average volume, and has calculated support and resistance at $35.46 and $41.88 respectively. Traders like to use volume as their lie detector for price action moves through predefined trading ranges.
The overall market index S&P 500 is trading lower by -0.35% from its previous trading close, which means that Eli Lilly stock is underperforming the overall market.
Related Articles
- Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
- Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
- Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
- DiversityInc Names Lilly a Top Company for Diversity
- Stock Futures Higher on Apple’s Blowout Quarter. Stocks to Watch: AAPL, AN, BIDU, BAC, CAT, CLF, LLY, QCOM, SAP
- Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises EPS Guidance
- Lilly Declares Second-Quarter 2012 Dividend
- Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign
- Reintegration Awards Recognize Service to People With Mental Illness
- Lilly Confirms Date and Conference Call for First-Quarter 2012 Financial Results Announcement
Related Partner Headlines
- Eli Lilly And Company (LLY): Today's Featured Health Care Loser - TheStreet.com
- Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY) - TheStreet.com
- Diary of a Dividend Diva: Buckle Up - TheStreet.com
- UPDATE: Bank of America Increases PO on Eli Lilly & Co to $46 - Benzinga
- Eli Lilly And Company (LLY): Today's Featured Drugs Winner - TheStreet.com
- Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto tablets, now available in U.S. pharmacies - Benzinga
- UPDATE: JP Morgan Upgrades Eli Lilly to Neutral - Benzinga
- Dividend Stocks Will Be Winners for a Whole Decade - TheStreet.com
- Eli Lilly And Stock To Go Ex-dividend Monday (LLY) - TheStreet.com
- New Study Evaluates Cialis in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia - Benzinga
JIM CRAMER wants to work for YOU. JIM does the research -- YOU get email alerts each time he trades. JIM provides access to his actual portfolio -- YOU can use it to guide your portfolio strategy.
Try Jim's Action Alerts PLUS for FREE!
TradersHuddle Search
| Sponsored By:
|
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
Stock Market
Loading
